Literature DB >> 12437330

Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C.

Yolanda Palom1, Gopinatha Suresh Kumar, Li-Qian Tang, Manuel M Paz, Steven M Musser, Sara Rockwell, Maria Tomasz.   

Abstract

Mitomycin C (MC), a cytotoxic anticancer drug and bifunctional DNA DNA alkylating agent, induces cross-linking of the complementary strands of DNA. The DNA interstrand cross-links (ICLs) are thought to be the critical cytotoxic lesions produced by MC. Decarbamoyl mitomycin C (DMC) has been regarded as a monofunctional mitomycin, incapable of causing ICLs. Paradoxically, DMC is slightly more toxic than MC to hypoxic EMT6 mouse mammary tumor cells as well as to CHO cells. To resolve this paradox, EMT6 cells were treated with MC or DMC under hypoxia at equimolar concentrations and the resulting DNA adducts were analyzed using HPLC and UV detection. MC treatment generated both intrastrand and interstrand cross-link adducts and four monoadducts, as shown previously. DMC generated two stereoisomeric monoadducts and two stereoisomeric ICL adducts, all of which were structurally characterized; one was identical with that formed with MC, the other was new and unique to DMC. Overall, adduct frequencies were strikingly higher (20-30-fold) with DMC than with MC. Although DMC monoadducts greatly exceeded DMC cross-link adducts ( approximately 10:1 ratio), the latter were equal or higher in number than the cross-link adducts from MC. DMC displayed a much higher monoadduct:cross-link ratio than MC. The similar cytotoxicities of the two drug show a correlation with their similar DNA cross-link adduct frequencies, but not with their total adduct or monoadduct frequencies. This provides specific experimental evidence that the ICLs rather than the monoadducts are critical factors in the cell death induced by MC. In vitro, overall alkylation of calf thymus DNA by DMC was much less efficient than by MC. Nevertheless, ICLs formed with DMC were clearly detectable. The chemical pathway of the cross-linking was shown to be analogous to that occurring with MC. These results also suggest that the differential sensitivity of Fanconi's Anemia cells to MC and DMC is related to factors other than a selective defect in cross-link repair.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437330     DOI: 10.1021/tx020044g

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  39 in total

1.  Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.

Authors:  Manuel M Paz; Sweta Ladwa; Elise Champeil; Yanfeng Liu; Sara Rockwell; Ernest K Boamah; Jill Bargonetti; John Callahan; John Roach; Maria Tomasz
Journal:  Chem Res Toxicol       Date:  2008-12       Impact factor: 3.739

2.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

3.  Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C.

Authors:  William Aguilar; Manuel M Paz; Anayatzinc Vargas; Maggie Zheng; Shu-Yuan Cheng; Elise Champeil
Journal:  Chemistry       Date:  2018-08-10       Impact factor: 5.236

4.  Involvement of Akt in mitomycin C and its analog triggered cytotoxicity in MCF-7 and K562 cancer cells.

Authors:  Shu-Yuan Cheng; Anayatzinc Vargas; Ji-Young Lee; Cristina C Clement; Elise Champeil
Journal:  Chem Biol Drug Des       Date:  2018-09-11       Impact factor: 2.817

Review 5.  Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approaches.

Authors:  Phillip D Bass; Daniel A Gubler; Ted C Judd; Robert M Williams
Journal:  Chem Rev       Date:  2013-05-08       Impact factor: 60.622

6.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

7.  Differential toxicity of DNA adducts of mitomycin C.

Authors:  Jill Bargonetti; Elise Champeil; Maria Tomasz
Journal:  J Nucleic Acids       Date:  2010-07-29

Review 8.  Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics.

Authors:  Catherine Silvestri; Jennifer S Brodbelt
Journal:  Mass Spectrom Rev       Date:  2012-11-13       Impact factor: 10.946

9.  Protective effect of melatonin against mitomycin C-induced genotoxic damage in peripheral blood of rats.

Authors:  S Ortega-Gutiérrez; M López-Vicente; F Lostalé; L Fuentes-Broto; E Martínez-Ballarín; J J García
Journal:  J Biomed Biotechnol       Date:  2009-10-20

10.  The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links.

Authors:  Ali Z Al-Minawi; Yin-Fai Lee; Daniel Håkansson; Fredrik Johansson; Cecilia Lundin; Nasrollah Saleh-Gohari; Niklas Schultz; Dag Jenssen; Helen E Bryant; Mark Meuth; John M Hinz; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2009-08-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.